Joint analysis of individual participants’ data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index

References

• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047–53
   PubMed Web of Science ®Google Scholar
• Kempf K, Rathmann W, Herder C. Impaired glucose regulation and type 2 diabetes in children and adolescents. Diabetes Metab Res Rev. 2008 Jun 13 ( Epub ahead of print).
   Google Scholar
• Das SK, Elbein SC. The genetic basis of type 2 diabetes. Cellscience. 2006; 2: 100–31
   Google Scholar
• Carey AL, Bruce CR, Sacchetti M, Anderson MJ, Olsen DB, Saltin B, et al. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia. 2004; 47: 1029–37
   PubMed Web of Science ®Google Scholar
• Andreozzi F, Laratta E, Cardellini M, Marini MA, Lauro R, Hribal ML, et al. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes. 2006; 55: 2021–4
   PubMed Web of Science ®Google Scholar
• Henningsson S, Hakansson A, Westberg L, Baghaei F, Rosmond R, Holm G, et al. Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women. Obesity. 2006; 14: 1868–73
   PubMedGoogle Scholar
• Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, et al. Sex Differences in the prediction of type 2 diabetes by inflammatory markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Diabetes Care. 2007; 30: 854–60
   Google Scholar
• Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102: 1369–76
   PubMed Web of Science ®Google Scholar
• Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000; 275: 18138–44
   PubMed Web of Science ®Google Scholar
• Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001; 21: 1458–63
   PubMed Web of Science ®Google Scholar
• Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, Green F, et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?. Clin Chem. 2004; 50: 2136–40
   PubMed Web of Science ®Google Scholar
• Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke. 2003; 34: 1864–9
   PubMed Web of Science ®Google Scholar
• Gaudino M, Andreotti F, Zamparelli R, Di Castelnuovo A, Nasso G, Burzotta F, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 2003; 108(Suppl 1)II195–9
   PubMedGoogle Scholar
• Kilpinen S, Hulkkonen J, Wang XY, Hurme M. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw. 2001; 12: 62–8
   PubMed Web of Science ®Google Scholar
• Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, et al. The interleukin-6 (−174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet. 2003; 112: 409–13
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes. 2000; 49: 517–20
   PubMed Web of Science ®Google Scholar
• Berthier MT, Paradis AM, Tchernof A, Bergeron J, Prud'homme D, Despres JP, et al. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet. 2003; 48: 14–19
   Google Scholar
• Klipstein-Grobusch K, Möhlig M, Spranger J, Hoffmann K, Rodrigues FU, Sharma AM, et al. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study. Obes Res. 2006; 14: 14–18
   Google Scholar
• Walch K, Grimm C, Zeillinger R, Huber JC, Nagele F, Hefler LA. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome. Fertil Steril. 2004; 81: 1638–41
   PubMed Web of Science ®Google Scholar
• Grallert H, Huth C, Kolz M, Meisinger C, Herder C, Strassburger K, et al. IL-6 promoter polymorphisms and quantitative traits related to the metabolic syndrome in KORA S4. Exp Gerontol. 2006; 41: 737–45
   Google Scholar
• Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l′Infarctus du Myocarde. J Mol Med. 2001; 79: 300–5
   Google Scholar
• Hamid YH, Rose CS, Urhammer SA, Glumer C, Nolsoe R, Kristiansen OP, et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia. 2005; 48: 251–60
   Google Scholar
• Sie MP, Sayed–Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, et al. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol. 2006; 26: 212–7
   Google Scholar
• Qi L, van Dam RM, Meigs JB, Manson JE, Hunter D, Hu FB. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet. 2006; 15: 1914–20
   Google Scholar
• Huth C, Heid IM, Vollmert C, Gieger C, Grallert H, Wolford JK, et al. IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes. 2006; 55: 2915–21
   Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539–58
   PubMed Web of Science ®Google Scholar
• Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999; 18: 321–59
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2004; 24: 1291–306
   Google Scholar
• Vaxillaire M, Veslot J, Dina C, Proenca C, Cauchi S, Charpentier G, et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes. 2008; 57: 244–54
   PubMed Web of Science ®Google Scholar
• Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med. 2002; 8: 75–9
   PubMed Web of Science ®Google Scholar
• van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab. 2003; 88: 3005–10
   PubMed Web of Science ®Google Scholar
• Lyngso D, Simonsen L, Bulow J. Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol. 2002; 543: 379–86
   PubMed Web of Science ®Google Scholar
• Barbieri M, Rizzo MR, Papa M, Acampora R, De Angelis L, Olivieri F, et al. Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors. Exp Gerontol. 2005; 40: 599–604
   PubMed Web of Science ®Google Scholar
• Qi L, Zhang C, van Dam RM, Hu FB. Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab. 2007; 92: 3618–25
   Google Scholar
• Bennet AM, Prince JA, Fei GZ, Lyrenas L, Huang Y, Wiman B, et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis. 2003; 171: 359–67
   PubMed Web of Science ®Google Scholar
• Herbert A, Liu C, Karamohamed S, Liu J, Manning A, Fox CS, et al. BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham Study. Obesity. 2006; 14: 1454–61
   Google Scholar
• van Oijen M, Arp PP, de Jong FJ, Hofman A, Koudstaal PJ, Uitterlinden AG, et al. Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci Lett. 2006; 402: 113–7
   PubMed Web of Science ®Google Scholar
• Walston JD, Fallin MD, Cushman M, Lange L, Psaty B, Jenny N, et al. IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum Genet. 2007; 122: 485–94
   Google Scholar
• Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, et al. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes. 2003; 52: 1872–6
   PubMed Web of Science ®Google Scholar
• Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, et al. The interleukin-6 ((174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet. 2003; 112: 409–13
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629–34
   PubMed Web of Science ®Google Scholar
• Wernstedt I, Eriksson AL, Berndtsson A, Hoffstedt J, Skrtic S, Hedner T, et al. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord. 2004; 28: 1272–9
   PubMed Web of Science ®Google Scholar
• Hamid YH, Rose CS, Urhammer SA, Glumer C, Nolsoe R, Kristiansen OP, et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia. 2005; 48: 251–60
   Google Scholar
• Flavell DM, Ireland H, Stephens JW, Hawe E, Acharya J, Mather H, et al. Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes. Diabetes. 2005; 54: 582–6
   PubMed Web of Science ®Google Scholar
• Mohlig M, Boeing H, Spranger J, Osterhoff M, Kroke A, Fisher E, et al. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab. 2004; 89: 1885–90
   Google Scholar
• Valle T, Tuomilehto J, Bergman RN, Ghosh S, Hauser ER, Eriksson J, et al. Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care. 1998; 21: 949–58
   PubMed Web of Science ®Google Scholar
• Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD, et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes. 2004; 53: 1141–9
   PubMed Web of Science ®Google Scholar
• Wichmann HE, Gieger C, Illig T. KORA-gen—resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005; 67(Suppl 1)S26–30
   Google Scholar
• Holle R, Happich M, Löwel H, Wichmann HE. KORA—a research platform for population based health research. Gesundheitswesen 2005; 67(Suppl 1)S19–25
   PubMedGoogle Scholar
• Lowel H, Doring A, Schneider A, Heier M, Thorand B, Meisinger C. The MONICA Augsburg surveys—basis for prospective cohort studies. Gesundheitswesen 2005; 67(Suppl 1)S13–18
   PubMed Web of Science ®Google Scholar
• Rathmann W, Haastert B, Icks A, Löwel H, Meisinger C, Holle R, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003; 46: 182–9
   Google Scholar
• Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, et al. Sex Differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Diabetes Care. 2007; 30: 854–60
   Google Scholar
• Broeckel U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, Comuzzie AG, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet. 2002; 30: 210–4
   PubMed Web of Science ®Google Scholar
• Stephens JW, Hurel SJ, Cooper JA, Acharya J, Miller GJ, Humphries SE. A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab. 2004; 82: 180–6
   Google Scholar
• Lieb W, Pavlik R, Erdmann J, Mayer B, Holmer SR, Fischer M, et al. No association of interleukin-6 gene polymorphism ((174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol. 2004; 97: 205–12
   Google Scholar
• Illig T, Bongardt F, Schopfer A, Muller-Scholze S, Rathmann W, Koenig W, et al. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab. 2004; 89: 5053–8
   PubMed Web of Science ®Google Scholar